Pharmaceuticals 11 min readApr 30, 2026

DSCSA at scale: what Indian pharma exporters must do before Q4

A practical playbook for serialization, aggregation and NBR-secured verification across US-bound supply chains.

Dr. Kavya Menon

Head of Pharma Compliance

The DSCSA enforcement window is closing. Exporters without unit-level authentication risk shipment holds at US ports.

Serialization alone is insufficient — verification at every hop is now the compliance standard.

Companion guide

Benchmarks, ROI math and rollout templates — free for enterprise teams.

Counterfeits erode revenue, but the deeper damage is to brand equity, consumer trust and regulatory standing.

Standard QR codes are trivially copyable. Non-Reproducible Barcodes shift authentication from readable to physically unclonable.

Boards are no longer asking 'where is the shipment?' — they are asking 'can we prove it was never tampered with?'

8 articles in the Knowledge Center.

Related articles